Canada Markets open in 1 hr 9 mins

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.03-0.33 (-6.16%)
At close: 04:00PM EST
5.03 0.00 (0.00%)
After hours: 06:03PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.43
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 358.37
52 Week Low 35.01
50-Day Moving Average 36.51
200-Day Moving Average 311.79

Share Statistics

Avg Vol (3 month) 3183.35k
Avg Vol (10 day) 3213.66k
Shares Outstanding 534.22M
Implied Shares Outstanding 6N/A
Float 832.65M
% Held by Insiders 17.86%
% Held by Institutions 157.84%
Shares Short (Oct. 14, 2021) 44.59M
Short Ratio (Oct. 14, 2021) 423.36
Short % of Float (Oct. 14, 2021) 418.55%
Short % of Shares Outstanding (Oct. 14, 2021) 413.33%
Shares Short (prior month Sep. 14, 2021) 45.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin -152.00%
Operating Margin (ttm)-151.36%

Management Effectiveness

Return on Assets (ttm)-15.70%
Return on Equity (ttm)-32.71%

Income Statement

Revenue (ttm)35.27M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)10.50%
Gross Profit (ttm)4.96M
EBITDA -51.39M
Net Income Avi to Common (ttm)-53.6M
Diluted EPS (ttm)-10.29
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)168.89M
Total Cash Per Share (mrq)4.91
Total Debt (mrq)46.37M
Total Debt/Equity (mrq)27.93
Current Ratio (mrq)19.09
Book Value Per Share (mrq)-25.04

Cash Flow Statement

Operating Cash Flow (ttm)-68.71M
Levered Free Cash Flow (ttm)-57.23M